Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Arch Soc Esp Oftalmol (Engl Ed) ; 97(8): 477-480, 2022 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-35914892

RESUMO

Clinical case of a 42-year-old woman who consulted for decreased vision in the left eye over two months, associated with multifocal choroiditis. Different diagnostic tests were performed to rule out infectious pathologies, as well as a diagnostic vitrectomy test, which was negative. QuantiFERON® was found to be positive and a diagnosis of serpeginous-like choroiditis (SLC) was made. Anti-tuberculosis treatment was started with worsening of vision and multifocal choroiditis. Once conventional immunotherapy and biological treatment were added, the patient presented a significant improvement in vision. To conclude, in cases of CSL, it is not only necessary to treat the infection but also the inflammatory component either with steroids or conventional immunotherapy or immunosuppression with biologics, thus reducing the number of reactivations and improving the visual prognosis.


Assuntos
Corioidite , Adalimumab/uso terapêutico , Adulto , Corioidite/diagnóstico , Corioidite/tratamento farmacológico , Diagnóstico Diferencial , Feminino , Humanos , Coroidite Multifocal , Prognóstico
2.
Arch. Soc. Esp. Oftalmol ; 97(8): 477-480, ago. 2022. ilus
Artigo em Espanhol | IBECS | ID: ibc-209099

RESUMO

Se presenta el caso clínico de una mujer de 42 años, que consultó por disminución de visión del ojo izquierdo de 2 meses evolución, asociada a coroiditis multifocal. Se realizaron diferentes pruebas diagnósticas para descartar enfermedad infecciosa, al igual que se realizó una vitrectomía diagnóstica, que resultó negativa. Se encontró QuantiFERON® positivo y se realizó el diagnóstico de coroiditis serpiginosa-like (CS-L). Se inició tratamiento antituberculoso con empeoramiento de la visión y de la coroiditis multifocal. Una vez que se agregaron inmunoterapia convencional y tratamiento biológico, la paciente presentó mejoría significativa de la visión. Para concluir, en casos de CS-L no solo es necesario el tratamiento de la infección, sino también del componente inflamatorio, sea con inmunoterapia convencional o inmunosupresión con biológicos, y así disminuir el número de reactivaciones mejorando el pronóstico visual (AU)


Clinical case of a 42-year-old woman who consulted for decreased vision in the left eye over 2months, associated with multifocal choroiditis. Different diagnostic tests were performed to rule out infectious pathologies, as well as a diagnostic vitrectomy test, which was negative. QuantiFERON® was found to be positive and a diagnosis of serpiginous-like choroiditis (SLC) was made. Anti-tuberculosis treatment was started with worsening of vision and multifocal choroiditis. Once conventional immunotherapy and biological treatment were added, the patient presented a significant improvement in vision. To conclude, in cases of SLC, it is not only necessary to treat the infection but also the inflammatory component either with steroids or conventional immunotherapy or immunosuppression with biologics, thus reducing the number of reactivations and improving the visual prognosis (AU)


Assuntos
Humanos , Feminino , Adulto , Anti-Inflamatórios/uso terapêutico , Adalimumab/uso terapêutico , Corioidite/tratamento farmacológico , Corioidite/diagnóstico , Resultado do Tratamento , Diagnóstico Diferencial , Prognóstico
3.
Arch Soc Esp Oftalmol (Engl Ed) ; 97(4): 224-229, 2022 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-35523469

RESUMO

Idiopathic macular telangiectasia type 2 (MacTel 2) is a slow and progressive bilateral condition that affects middle-aged and elderly individuals. Vision loss is generally mild and occurs over the course of many years. The development of sub-retinal neovascularisation (SRNV) can occur late in the disease process, and lead to more dramatic vision loss. A report is presented of 2 cases of MacTel 2 in which optical coherence tomography angiography (OCTA) was essential for the diagnosis of secondary SRNV. The commercially available OCTA Cirrus AngioPlex 5000 platform (Zeiss, Jena, Germany) was used. Subretinal neovascularization was detectable in both cases in OCTA at the level of the deep capillary plexus and the avascular layer. OCTA also allowed us to monitor disease progression and monitor response to anti-VEGF therapy.


Assuntos
Neovascularização Retiniana , Telangiectasia Retiniana , Idoso , Angiografia , Humanos , Pessoa de Meia-Idade , Neovascularização Retiniana/diagnóstico por imagem , Neovascularização Retiniana/tratamento farmacológico , Neovascularização Retiniana/etiologia , Telangiectasia Retiniana/complicações , Telangiectasia Retiniana/diagnóstico por imagem , Tomografia de Coerência Óptica/métodos
4.
Arch. Soc. Esp. Oftalmol ; 97(4): 224-229, abr. 2022. ilus
Artigo em Espanhol | IBECS | ID: ibc-208844

RESUMO

La telangiectasia macular idiopática tipo 2 (MacTel 2) es una afección bilateral, lenta y progresiva que afecta a individuos de mediana edad y ancianos. La pérdida de visión es generalmente leve y ocurre en el transcurso de muchos años. El desarrollo de neovascularización subretiniana (NVSR) puede ocurrir tarde en el proceso de la enfermedad y conducir a una pérdida de visión más dramática. Presentamos 2casos de MacTel 2 donde la angiografía por tomografía de coherencia óptica (OCTA) fue fundamental para el diagnóstico de NVSR secundaria. Se utilizó la plataforma comercialmente disponible OCTA Cirrus AngioPlex 5000 (Zeiss, Jena, Alemania). La NVSR fue detectable en ambos casos con OCTA a nivel del plexo capilar profundo y en la capa avascular. La OCTA también nos permitió controlar la progresión de la enfermedad y monitorizar la respuesta a la terapia anti-VEGF (AU)


Idiopathic macular telangiectasia type 2 (MacTel 2) is a slow and progressive bilateral condition that affects middle-aged and elderly individuals. Vision loss is generally mild and occurs over the course of many years. The development of sub-retinal neovascularisation (SRNV) can occur late in the disease process, and lead to more dramatic vision loss. A report is presented of 2cases of MacTel 2 in which optical coherence tomography angiography (OCTA) was essential for the diagnosis of secondary SRNV. The commercially available OCTA Cirrus AngioPlex 5000 platform (Zeiss, Jena, Germany) was used. Subretinal neovascularization was detectable in both cases in OCTA at the level of the deep capillary plexus and the avascular layer. OCTA also allowed us to monitor disease progression and monitor response to anti-VEGF therapy (AU)


Assuntos
Humanos , Feminino , Adulto , Pessoa de Meia-Idade , Angiografia/métodos , Tomografia de Coerência Óptica , Telangiectasia Retiniana/diagnóstico por imagem , Telangiectasia Retiniana/complicações , Neovascularização Retiniana/diagnóstico por imagem , Neovascularização Retiniana/etiologia
5.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-33495053

RESUMO

Idiopathic macular telangiectasia type 2 (MacTel 2) is a slow and progressive bilateral condition that affects middle-aged and elderly individuals. Vision loss is generally mild and occurs over the course of many years. The development of sub-retinal neovascularisation (SRNV) can occur late in the disease process, and lead to more dramatic vision loss. A report is presented of 2cases of MacTel 2 in which optical coherence tomography angiography (OCTA) was essential for the diagnosis of secondary SRNV. The commercially available OCTA Cirrus AngioPlex 5000 platform (Zeiss, Jena, Germany) was used. Subretinal neovascularization was detectable in both cases in OCTA at the level of the deep capillary plexus and the avascular layer. OCTA also allowed us to monitor disease progression and monitor response to anti-VEGF therapy.

6.
Arch. Soc. Esp. Oftalmol ; 93(7): 342-346, jul. 2018. ilus
Artigo em Espanhol | IBECS | ID: ibc-174911

RESUMO

CASO CLÍNICO: Se presenta un caso clínico poco frecuente de una mujer de 15 años afectada por múltiples desprendimientos serosos bilaterales de retina y epitelio pigmentario. Con el diagnóstico clínico y de laboratorio (inmunofluorescencia indirecta [IFI] IgG 1/160 e IgM 1/160) de leptospirosis se realizó un examen oftalmológico completo, angiofluoresceingrafía, autofluorescencia y tomografía de coherencia óptica y se siguió al paciente durante 2 años. Discusión: Los desprendimientos serosos bilaterales y múltiples de la retina y del epitelio pigmentario pueden ser una complicación de la leptospirosis sistémica, zoonosis causada por Leptospira. Sin una historia médica detallada, puede permanecer sin ser diagnosticada, principalmente porque puede imitar otras enfermedades más frecuentes. Puede ser prudente preguntar a los pacientes sobre contacto con mascotas


CLINICAL CASE: An uncommon case is presented of a 15 year-old girl with bilateral, multiple serous detachments of retina and retinal pigment epithelium. With clinical and laboratory (IgG 1/160 and IgM 1/160, using an indirect immunofluorescence assay) diagnoses of leptospirosis, a complete ophthalmic examination, fluorescein angiography, autofluorescence and optical coherence tomography were performed, and the patient was followed for two years. DISCUSSION: Bilateral, multiple serous detachments of retina and retinal pigment epithelium can be a complication of systemic leptospirosis, a zoonotic disease caused by Leptospira. Without a detailed medical history it may be underdiagnosed, mainly because it can mimic other more common diseases. It may be prudent to ask patients regarding contact with pets


Assuntos
Humanos , Feminino , Adolescente , Descolamento Retiniano/diagnóstico por imagem , Leptospirose/complicações , Leptospirose/diagnóstico , Acuidade Visual , Técnica Indireta de Fluorescência para Anticorpo/métodos , Tomografia de Coerência Óptica/métodos , Retina/diagnóstico por imagem , Retina/fisiopatologia
7.
Arch. Soc. Esp. Oftalmol ; 93(3): 147-150, mar. 2018. ilus
Artigo em Espanhol | IBECS | ID: ibc-172249

RESUMO

Introducción: Adalimumab, un antifactor de necrosis tumoral que se utiliza en la enfermedad de Crohn activa (EC), se asocia con un mayor riesgo de tuberculosis. Caso clínico: Se describe el caso de un varón de 48 años con EC activa en tratamiento con adalimumab. Después de 3 meses desarrolló una tuberculosis pulmonar miliar, y en un estudio oftalmológico se encontró un tubérculo coroideo no reactivo solitario temporal superior al disco óptico. La angiofluoresceingrafía mostró hiperfluorescencia tardía. Con la tomografía de coherencia óptica se observó una masa plana sin desprendimiento seroso de retina. El tubérculo coroideo regresó lentamente con la terapia antituberculosa. Discusión: En pacientes con EC y en tratamiento con adalimumab, un tubérculo coroideo puede presentarse sin sintomatología vítreo-retiniana (AU)


Introduction: Adalimumab, an anti-tumour necrosis factor alpha therapy for active Crohn's disease (CD), is associated with increased risks of tuberculosis infection. Case report: The case is presented of a 48 year-old male with active CD on treatment with adalimumab. After three months, he developed a miliary pulmonary tuberculosis infection, with a solitary non-reactive choroidal tubercle temporal-superior to the optic disc being found in an ophthalmological study. Fluorescein angiography showed late hyperfluorescence in a staining pattern. Optic coherence tomography showed a flat mass without serous retinal detachment. The choroidal tubercle slowly regressed with antituberculosis therapy. Discussion: Choroidal tubercles with no vitreo-retinal symptomatology can be present in patients with CD and on treatment with adalimumab (AU)


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Doenças da Coroide/diagnóstico , Tuberculose Ocular/complicações , Doença de Crohn/complicações , Adalimumab/efeitos adversos , Fatores de Risco , Tomografia de Coerência Óptica , Antituberculosos/uso terapêutico , Terapia Biológica/efeitos adversos , Tuberculose Miliar/complicações
8.
Arch Soc Esp Oftalmol (Engl Ed) ; 93(7): 342-346, 2018 Jul.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-29398239

RESUMO

CLINICAL CASE: An uncommon case is presented of a 15 year-old girl with bilateral, multiple serous detachments of retina and retinal pigment epithelium. With clinical and laboratory (IgG 1/160 and IgM 1/160, using an indirect immunofluorescence assay) diagnoses of leptospirosis, a complete ophthalmic examination, fluorescein angiography, autofluorescence and optical coherence tomography were performed, and the patient was followed for two years. DISCUSSION: Bilateral, multiple serous detachments of retina and retinal pigment epithelium can be a complication of systemic leptospirosis, a zoonotic disease caused by Leptospira. Without a detailed medical history it may be underdiagnosed, mainly because it can mimic other more common diseases. It may be prudent to ask patients regarding contact with pets.


Assuntos
Leptospirose/complicações , Descolamento Retiniano/microbiologia , Epitélio Pigmentado da Retina , Adolescente , Feminino , Humanos , Retina
9.
Arch Soc Esp Oftalmol (Engl Ed) ; 93(3): 147-150, 2018 Mar.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-28743416

RESUMO

INTRODUCTION: Adalimumab, an anti-tumour necrosis factor alpha therapy for active Crohn's disease (CD), is associated with increased risks of tuberculosis infection. CASE REPORT: The case is presented of a 48 year-old male with active CD on treatment with adalimumab. After three months, he developed a miliary pulmonary tuberculosis infection, with a solitary non-reactive choroidal tubercle temporal-superior to the optic disc being found in an ophthalmological study. Fluorescein angiography showed late hyperfluorescence in a staining pattern. Optic coherence tomography showed a flat mass without serous retinal detachment. The choroidal tubercle slowly regressed with antituberculosis therapy. DISCUSSION: Choroidal tubercles with no vitreo-retinal symptomatology can be present in patients with CD and on treatment with adalimumab.


Assuntos
Adalimumab/efeitos adversos , Anti-Inflamatórios/efeitos adversos , Doenças da Coroide/induzido quimicamente , Doença de Crohn/tratamento farmacológico , Tuberculose Ocular/induzido quimicamente , Adalimumab/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Doenças Assintomáticas , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...